The Cardioprotective Properties of Agaricomycetes Mushrooms Growing in the Territory of Armenia: Review

Badalyan, Susanna M.; Barkhudaryan, Anush; Rapior, Sylvie

doi:10.1615/intjmedmushrooms.2021038280

Cited by 13 publications

(2 citation statements)

References 51 publications

(87 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Species that produce secondary metabolites that have a wide range of biological activities are considered as medicinal macrofungi [59]. Many studies have documented the medicinal properties of mushrooms, including antitumor [60], immunomodulating, antioxidant [61], radical scavenging, cardiovascular-protective [62], antihypercholesterolemia, antiviral, antibacterial, antiparasitic, antifungal, detoxifying, hepatoprotective, and antidiabetic effects [63]. Many polysaccharides or polysaccharide-protein complexes exhibit antitumor activities in animals and humans by enhancing innate and cell-mediated immune response [60].…”

Section: Nutraceuticalsmentioning

confidence: 99%

Macrofungi as a Nutraceutical Source: Promising Bioactive Compounds and Market Value

Niego

Rapior

Thongklang

et al. 2021

JoF

Self Cite

View full text Add to dashboard Cite

Macrofungi production and economic value have been increasing globally. The demand for macrofungi has expanded rapidly owing to their popularity among consumers, pleasant taste, and unique flavors. The presence of high quality proteins, polysaccharides, unsaturated fatty acids, minerals, triterpene sterols, and secondary metabolites makes macrofungi an important commodity. Macrofungi are well known for their ability to protect from or cure various health problems, such as immunodeficiency, cancer, inflammation, hypertension, hyperlipidemia, hypercholesterolemia, and obesity. Many studies have demonstrated their medicinal properties, supported by both in vivo and in vitro experimental studies, as well as clinical trials. Numerous bioactive compounds isolated from mushrooms, such as polysaccharides, proteins, fats, phenolic compounds, and vitamins, possess strong bioactivities. Consequently, they can be considered as an important source of nutraceuticals. Numerous edible mushrooms have been studied for their bioactivities, but only a few species have made it to the market. Many species remain to be explored. The converging trends and popularity of eastern herbal medicines, natural/organic food product preference, gut-healthy products, and positive outlook towards sports nutrition are supporting the growth in the medicinal mushroom market. The consumption of medicinal mushrooms as functional food or dietary supplement is expected to markedly increase in the future. The global medicinal mushroom market size is projected to increase by USD 13.88 billion from 2018 to 2022. The global market values of promising bioactive compounds, such as lentinan and lovastatin, are also expected to rise. With such a market growth, mushroom nutraceuticals hold to be very promising in the years to come.

show abstract

Section: Nutraceuticalsmentioning

confidence: 99%

Macrofungi as a Nutraceutical Source: Promising Bioactive Compounds and Market Value

Niego

Rapior

Thongklang

et al. 2021

JoF

Self Cite

View full text Add to dashboard Cite

show abstract

“…Singer. They are producers of phenolic compounds, terpenoids, polysaccharides, fatty acids, proteins, lectins, diterpenoid eryngiolide A, ergothioneine and other biomolecules with antitumor, antimicrobial, antioxidant, hypoglycemic, hypocholesterolemic, hepatoprotective, neurotoxic, cardioprotective and other therapeutic effects [2,[12][13][14][15][16][17][18][19][20][21][22].…”

mentioning

confidence: 99%

Biomass Formation by Different Collections of $Pleurotus$ Spp. During Submerged Growth

Badalyan,

Gharibyan

2023

Proc. YSU B: Chem. Biol. Sci.

View full text Add to dashboard Cite

Many species of the genus Pleurotus (Fr.) P. Kumm. (Oyster mushrooms) are known as valuable edible and medicinal fungi, cultivated worldwide. The studied 18 different collections of five Pleurotus species (P. ostreatus, P. cornucopiae, P. eryngii, P. pulmonarius, and P. cystidiosus) during submerged growth in malt extract medium formed round shaped fluffy pellets and disperse mycelium. After seven days of cultivation, they accumulated up to 29.46 g/L biomass, while after 14 days the amount increased up to 40.4 g/L, reaching the value of commercial P. ostreatus 22 strain. More than 30.0 g/L biomass was formed in nine from 12 P. ostreatus collections, among which Armenian (SB24 and SB25), French (Po/28) and Spanish (N001) strains, as ecologically safe resources are perspective for further study to develop mushroom-based biotech products, food, pharmaceuticals and cosmeceticals.

show abstract

Flammulina velutipes (Curtis) Singer - PHYSALACRIACEAE

Gafforov,

Badalyan,

Rašeta

et al. 2023

Ethnobiology

View full text Add to dashboard Cite

The Cardioprotective Properties of Agaricomycetes Mushrooms Growing in the Territory of Armenia: Review

Cited by 13 publications

References 51 publications

Macrofungi as a Nutraceutical Source: Promising Bioactive Compounds and Market Value

Macrofungi as a Nutraceutical Source: Promising Bioactive Compounds and Market Value

Biomass Formation by Different Collections of $Pleurotus$ Spp. During Submerged Growth

Flammulina velutipes (Curtis) Singer - PHYSALACRIACEAE

Contact Info

Product

Resources

About